Respiratory Syncytial Virus study: H5 Flu IMP vs RSV IMP
Official title Study of Different Formulations of Vaccines Encoding the RSV Monovalent Antigen or the Flu H5 Antigen in Participants 18 to 49 Years of Age
ClinicalTrials.gov ID: NCT07516418
What this study is testing
What is H5 Flu Investigational Medical Product (IMP) 1?
H5 Flu Investigational Medical Product (IMP) 1 is an investigational medicine, given as an injection into a muscle, being studied as a potential treatment for respiratory syncytial virus (rsv).
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The study aims to see if the vaccines are safe and if they trigger an immune response.
- Who it's for
- Healthy men and women ages 18 to 49 are being recruited.
- What's involved
- Participants will receive a study vaccine and have regular check‑ups and blood draws to monitor safety and immunity.
- Time commitment
- Participation lasts about 6–7 months with several clinic visits over that time.
- Phase 1: an early, usually small safety study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 49. Healthy volunteers may be eligible.
You may be able to join if
- Aged 18 to 49 years on the day of inclusion
- Is of NCBP (Non-Child-Bearing Potential). To be considered of NCBP, a female must be post-menopausal for at least 1 year, or surgically sterile. OR
- Is of CBP (Child-Bearing Potential) and uses an effective contraceptive method or abstinence from at least 4 weeks prior to study intervention...
You likely can't join if
- Any condition which, in the opinion of the Investigator, might interfere with the evaluation of the study objectives
- The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
The study team makes the final eligibility decision.
Where it is enrolling
- Griffith, Queensland, Australia
- Herston, Queensland, Australia
- Morayfield, Queensland, Australia
- Sippy Downs, Queensland, Australia
- South Brisbane, Queensland, Australia
- Taringa, Queensland, Australia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 49 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Griffith, Queensland, Australia; Herston, Queensland, Australia; Morayfield, Queensland, Australia; Sippy Downs, Queensland, Australia; South Brisbane, Queensland, Australia; Taringa, Queensland, Australia. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.